Genetic alteration associated with response to radiotherapy in advanced cervical cancer
Genetic alteration associated with response to radiotherapy in advanced cervical cancer
批准号:
09670965
负责人:
HARIMA Yoko
金额:
$1.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Chromosome 17 alterations are found in more cancers than those of any other chromosome, and frequently involve the p53 gene on 17p13. The aim of this study was to identify the correlations between the presence of loss of heterozygosity (LOH) and microsatellite instability (MI) on chromosome 17p13 in patients with cervical cancer and the patients' response to radiotherapy. A total of 50 patients were treated with definitive radiotherapy. We performed biopsies and took specimens from the tumour and venous blood of all patients. Tumour and normal DNAs were analyzed by polyrnerase chain reaction for genetic losses and instability at three polymorphic microsatellite locimapped to 17p13. Nineteen of theSO tumours (38%) displayed a genetic alteration (GA) on 17p13, sixteen (32%) were found to have LOH, and 3(6%) showed MI.The sizes of the tumours of the GA-positive patients were significantly greater than those of the GA-negative patients (P=0.009). The mean tumour diameter of all patients wa … More s 6 * 2.4 cm. We divided the patients into those with tumours smaller than 6cm in diameter (n=26) and those with tumours equal to or greater than 6 cm in diameter (n=24). The former group survived significantly longer compared to the latter group(P=0.0002). Among the patients with < 6cm tumours, all 6 GA-positive patients are alive with no evidence of disease (NED), whereas of the 20 GA-negative patients, 18 have NED, and 2 are alive with disease (AWD) or suffered cancer-caused death (CD). Thus, there was no correlation between GA and radiotherapy response in the tumours smaller than 6 cm. However, among the patients with *6 cm turnours, 2 of the GA-positive patients have NED, and 11 are AWD/CD, whereas 7 of the GA-negative patients have NED, and 4 are AWD/CD.Among the patients with * 6 cm tumours, the response to radiotherapy of the GA-positive patients were significantly poorer than those of the GA-negative patients (P=0.02). In addition, the GA-negative patients survived significantly longer compared to the GA-positive patients (P=0.026). The results of this study suggest that GA increases with tumour growth. Improved success in the management of bulky cervical cancer requires a better understanding of its biological behavior. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Y Harima: "Bax and Bcl-2 expression predict response to radiotherapy in human cervical cancer." J.Cancer Res.Clin.Oncol.124. 503-510 (1998)
Y Harima:“Bax 和 Bcl-2 表达可预测人类宫颈癌对放射治疗的反应。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y Harima: "WAF1 induction and infection by HPV E6 as a determinants of radiosensitivity in human cervical cancer" Jpn, J, Cancer Clin.44. 185-186 (1998)
Y Harima:“HPV E6 诱导和感染 WAF1 作为人类宫颈癌放射敏感性的决定因素”Jpn,J,Cancer Clin.44。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y Harima: "Bax and Bcl-2 expression predict response to radiotherapy in human cervical cancer." Jpn.J.Cancer Chemother.25. 1273-1277 (1998)
Y Harima:“Bax 和 Bcl-2 表达可预测人类宫颈癌对放射治疗的反应。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M Imamura: "Relationship between LET and RBE values for Escherichia coli determined using carbon ion beams from the TIARA cyclotron and HIMAC synchrotron" J.Gen.Appl.Microbiol.43. 175-177 (1997)
M Imamura:“使用 TIARA 回旋加速器和 HIMAC 同步加速器的碳离子束确定大肠杆菌的 LET 和 RBE 值之间的关系”J.Gen.Appl.Microbiol.43。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M Imamura: "Potential applicability of clinical hyperthermia using a Thermotron-RF8 as assessedfrom thermal distribution in an agar phantom containing hydroxyapatite." Oncology Reports. 3. 1017-1019 (1997)
M Imamura:“根据含有羟基磷灰石的琼脂模型的热分布评估,使用 Thermotron-RF8 进行临床热疗的潜在适用性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Prediction of outcomes after radiotherapy for the patients with advanced cervical cancer using the molecular technique
-
批准号:25293266
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2013
-
负责人:HARIMA Yoko
-
依托单位:
Elucidation of the epigenetic gene control as the clinical strategiesfor the patients with radioresistant cervical cancer
-
批准号:23659597
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:HARIMA Yoko
-
依托单位:
Elucidation and conquest of the radioresistant for the patients with advanced cervical cancer using the molecular technique
-
批准号:22390237
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2010
-
负责人:HARIMA Yoko
-
依托单位:
The advantage of signal transduction as a translational research in cervical cancer after radiotherapy
-
批准号:14570885
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2002
-
负责人:HARIMA Yoko
-
依托单位:
Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy
-
批准号:11670919
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1999
-
负责人:HARIMA Yoko
-
依托单位:
Bax and Bcl-2 expression predict response to radiotherapy in advanced cervical cancer
-
批准号:07671037
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:HARIMA Yoko
-
依托单位:
海外基金